Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1996
12/27/1996WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
12/27/1996WO1996041624A1 TNF-α CONVERTING ENZYME
12/27/1996WO1996041607A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11
12/27/1996WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
12/27/1996EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination
12/27/1996EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase
12/27/1996EP0749753A2 Use of a powder or an extract of guava for treating allergic diseases
12/27/1996EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof
12/27/1996EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION
12/27/1996EP0749481A1 Humanized monoclonal antibodies against human interleukin-4
12/27/1996EP0749476A1 Mediators of chronic allograft rejection
12/27/1996EP0749434A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/27/1996EP0749429A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
12/27/1996EP0749428A1 Isoxazoline compounds as inhibitors of tnf release
12/27/1996EP0749417A1 Cyano compounds and preparations thereof
12/27/1996EP0749323A1 Methods for modulating t cell unresponsiveness
12/27/1996EP0749318A1 Method of stimulating hematopoiesis with hemoglobin
12/27/1996EP0749307A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
12/27/1996EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
12/27/1996EP0580641B1 New thalidomide derivatives, method of manufacture and use thereof in medicaments
12/27/1996CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
12/27/1996CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
12/25/1996CN1138865A Peptides and methods against psoriasis
12/25/1996CN1138861A 2-heteroaryl-5,11-dihydro-6H-dipyrido|3,2-b:2',3'-3¨|1,4¨diazepines and their use in the prevention or treatment of HIV infection
12/25/1996CN1138851A Metalloproteinase inhibitors
12/25/1996CN1033638C Novel alpha-mannosidase and fucosidase inhibitors
12/24/1996US5587480 Treating hiv and hepatitis virus infections
12/24/1996US5587460 Controller of cell differentiation; immunology
12/24/1996US5587360 Platelet adhesion inhibitor
12/24/1996US5587162 Administering to mammal a cytotoxin
12/19/1996WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines
12/19/1996WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses
12/19/1996WO1996040915A2 Novel ctla4/cd28 ligands and uses therefor
12/19/1996WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
12/19/1996WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES
12/19/1996WO1996040788A1 Anti-allergy bispecific molecules
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040740A1 Peptide and method of obtaining it
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040718A1 Expression of lipoproteins
12/19/1996WO1996040688A1 Triterpenes
12/19/1996WO1996040659A1 N-hydroxyureas as antiinflammatory agents
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists
12/19/1996WO1996040636A1 Catechol diethers derivatives useful as pharmaceutical agents
12/19/1996WO1996040633A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996WO1996040293A1 Structurally determined metallo-constructs and applications
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996WO1996040254A1 Polyphosphazene polyelectrolyte immunoadjuvants
12/19/1996WO1996040246A1 Treatment of t cell mediated autoimmune disorders
12/19/1996WO1996040241A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996WO1996040230A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996WO1996040224A1 Regulation of cytokine synthesis and release
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040197A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040157A1 USE OF ANTISENSE OLIGONUCLEOTIDES TO IL-6 RECEPTOR mRNA TO INHIBIT CELLULAR PROLIFERATION
12/19/1996WO1996040123A1 Antigen-processing cell-targeted conjugates
12/19/1996WO1996040116A1 Indolinone compounds for the treatment of disease
12/19/1996WO1996040081A2 Oral delivery of gene constructs
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2704354A1 Expression of lipoproteins
12/19/1996CA2252811A1 Polyphosphazene polyelectrolyte immunoadjuvants
12/19/1996CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996CA2223714A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996CA2223687A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/19/1996CA2223610A1 Nucleic acid respiratory syncytial virus vaccines
12/19/1996CA2223605A1 Stable formulations of mhc-peptide complexes
12/19/1996CA2223592A1 Triterpenes
12/19/1996CA2223416A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996CA2223303A1 Treatment of t cell mediated autoimmune disorders
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223109A1 Use of antisense oligonucleotides to il-6 receptor mrna to inhibit cellular proliferation
12/19/1996CA2222999A1 Novel ctla4/cd28 ligands and uses therefor
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996CA2221601A1 Regulation of cytokine synthesis and release
12/19/1996CA2221323A1 Oral delivery of gene constructs
12/19/1996CA2221146A1 Structurally determined metallo-constructs and applications
12/19/1996CA2220952A1 Anti-allergy bispecific molecules
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
12/18/1996EP0748336A1 Immunosuppressive compounds and method of preparing same
12/18/1996EP0748327A1 Structure of a novel lipid a and methods utilizing same
12/18/1996EP0748319A1 Process for making an epoxide
12/18/1996EP0748317A1 Novel thiazolidin-4-one derivatives
12/18/1996EP0748312A1 Bicyclic carbamates as leukotriene d4 antagonists
12/18/1996EP0748310A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
12/18/1996EP0526598B1 New pharmacologically active catechol derivatives
12/18/1996CN1138298A Vaccines
12/18/1996CN1033587C Preparation method of imidazo |1,2-a¨ (pyrrolo, thieno or furano)|3,2-d¨ azepine derivatives
12/18/1996CN1033586C Preparation method of imidazo |2,1-B¨ |3¨ benzazeping derivatives
12/18/1996CN1033583C Process for preparing 6-(substituted aminopropionyl) derivatives of forskolin
12/17/1996US5585499 Drug delivery
12/17/1996US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors
12/17/1996US5585467 Cultivating a mycins from fungus strain
1 ... 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 ... 1172